Biocon has reported results for third quarter ended December 31, 2023 (Q3FY24).
The company has reported 31.82% fall in its net profit at Rs 24.00 crore for Q3FY24 as compared to Rs 35.20 crore for the same quarter in the previous year. Total income of the company decreased by 0.59% at Rs 611.30 crore for Q3FY24 as compared Rs 614.90 crore for corresponding quarter of the previous year.
On consolidated basis, the company has reported net profit of Rs 753.30 crore for the third quarter ended December 31, 2023 as compared to net loss of Rs 20.70 crore for the same quarter in the previous year. Total income of the company increased by 49.66% at Rs 4,519.20 crore for Q3FY24 as compared Rs 3,019.70 crore for corresponding quarter of the previous year.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1849.05 |
Dr. Reddys Lab | 1274.25 |
Cipla | 1553.20 |
Lupin | 2184.00 |
Zydus Lifesciences | 1001.85 |
View more.. |